Pathogenesis and therapeutic strategies of osteoarthritis: roles of immune cells, inflammatory mediators, and pathogenic signaling pathways

Патогенез и терапевтические стратегии при остеоартрите: роль иммунных клеток, воспалительных медиаторов и патогенных сигнальных путей
Yi Cong Jin, Guanyu Chen, Zhenglin He, Xuechao Li, Hanming Hao, Baoer Chen, Dezhi Mao, Kai Zhao
2026-01-15

NF-κB and Wnt/β-catenin signalingimmune cellsinflammatory mediatorsosteoarthritisosteoimmunology
Osteoarthritis (OA), the leading global cause of joint-related disability, is increasingly viewed as an immune-mediated disorder rather than mere mechanical wear-and-tear. Yet how resident and infiltrating immune cells, inflammatory mediators and dysregulated signaling networks act in concert to perpetuate synovitis, erode cartilage and remodel subchondral bone remains a central enigma. This review dissects the cellular and molecular choreography underlying OA pathology. We detail how macrophages, dendritic cells (DCs), neutrophils, mast cells (MCs), natural killer cells (NK cells), T cells, and B cells orchestrate destructive immune-bone crosstalk within the joint microenvironment. Key inflammatory mediators such as tumor necrosis factor-alpha (TNF-α), transforming growth factor-beta (TGF-β), interleukins (e.g., interleukin (IL)-1β, IL-6), and chemokines sustain this inflammatory loop, further perpetuating inflammation and cartilage damage. Dysregulated signaling pathways, such as nuclear factor-kappa B (NF-κB) and Wingless-type (Wnt)/β-catenin, are coordinated with inflammatory mediators, thereby contributing to the pathophysiology of OA. Beyond mechanism, we critically evaluate cutting-edge therapeutic strategies targeting these osteoimmunological and molecular mechanisms, such as immunomodulatory therapy, mesenchymal stem cell (MSC) therapy and small-molecule pathway inhibitors. Preclinical successes underscore the feasibility of targeting immune-signaling axes to halt or reverse OA progression. By elucidating these mechanisms and therapeutic targets, this review aims to advance the development of disease-modifying therapies and improve outcomes for OA patients.
1
Dysregulated NF-κB and Wnt/β-catenin signaling pathways cooperate with inflammatory mediators to promote osteoarthritis pathophysiology.
2
Macrophages, dendritic cells, neutrophils, mast cells, natural killer cells, T cells, and B cells drive destructive immune–bone interactions in the joint.
3
Osteoarthritis is characterized as an immune-mediated disorder involving coordinated synovitis, cartilage erosion, and subchondral bone remodeling.
4
Preclinical evidence supports immunomodulatory therapies, mesenchymal stem cells, and small-molecule pathway inhibitors as potential disease-modifying strategies.
5
TNF-α, TGF-β, IL-1β, IL-6, and chemokines sustain inflammatory cycles that perpetuate synovitis and cartilage damage.

Osteoarthritis and its joint microenvironment, including synovial tissue, cartilage, and subchondral bone

Immune-cell and inflammatory-mediator interactions and dysregulated signaling pathways driving synovitis, cartilage erosion, subchondral bone remodeling, and therapeutic targeting of OA progression

Publication Details
Publication Date
2026-01-15
Journal
Publisher
ISSN
Cited by
17
Access Type
Author Information
Authors
Yi Cong Jin
Guanyu Chen
Zhenglin He
Xuechao Li
Hanming Hao
Baoer Chen
Dezhi Mao
Kai Zhao
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%